Publication at Faculty of Medicine in Pilsen |
2010
Abstract
Sublingual tablet for specific grass-pollen allergen immunotherapy has a well documented efficacy and safety in children, adolescents and adults. Indication of this vaccine responds highly to other allergen vaccines.